SOX9 and cancer: The relevance of our mouse model findings is reflected by marked reduction or loss of SOX9 protein expression in approximately 20% of primary CRCs, and the subset of patients with CRC whose cancers show marked reduction in SOX9 gene expression have poor prognosis.